bucladesine has been researched along with Reperfusion Injury in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bando, T; Chen, F; Date, H; Nakajima, D; Ohsumi, A; Sakamoto, J; Yamada, T | 1 |
| Chiang, CH; Lu, HL | 1 |
| Bando, T; Koshiba, T; Li, Y; Nakamura, T; Tanaka, K; Tsuruyama, T; Wada, H; Zhao, X | 1 |
| Chang, DM; Chiang, CH; Harn, HJ; Hsu, K; Yan, HC | 1 |
| Fukuse, T; Hirata, T; Hitomi, S; Nakamura, T; Ueda, M; Wada, H | 1 |
| Ishiguro, N; Iwata, H; Ohshima, T; Yabe, Y | 1 |
| Chang, DM; Chiang, CH; Hsu, K; Perng, WC; Wu, CP; Wu, K; Yan, HC; Yu, CP | 1 |
| Fukuse, T; Hasegawa, S; Hirata, T; Nakamura, T; Suzuki, Y; Ueda, M; Wada, H | 1 |
| Emala, CW; Lee, HT | 1 |
| Akbar, S; Minor, T | 1 |
| Barnard, J; Haynes, J; Seibert, AF; Taylor, A; Thompson, WJ; Wilborn, WH | 1 |
| Adkins, WK; Barnard, JW; Haynes, J; May, S; Seibert, AF; Taylor, AE | 1 |
12 other study(ies) available for bucladesine and Reperfusion Injury
| Article | Year |
|---|---|
Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion.
Topics: Adenosine Triphosphate; Animals; Bucladesine; Dogs; Lung; Lung Transplantation; Models, Animal; Nitroglycerin; Organ Preservation; Organ Preservation Solutions; Oxygen Consumption; Reperfusion; Reperfusion Injury; Time Factors; Tissue and Organ Harvesting; Warm Ischemia | 2012 |
Combined therapy of pentastarch, dexamethasone, and dibutyryl-cAMP or beta 2-agonist attenuates ischaemia/reperfusion injury of rat lung.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Bucladesine; Cytokines; Dexamethasone; Drug Therapy, Combination; Hydroxyethyl Starch Derivatives; Lung Injury; Male; Plasma Substitutes; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Reperfusion Injury; RNA, Messenger; Vascular Resistance | 2008 |
ET-Kyoto solution plus dibutyryl cyclic adenosine monophosphate is superior to University of Wisconsin solution in rat liver preservation.
Topics: Adenosine; Allopurinol; Animals; Apoptosis; Aspartate Aminotransferases; Bucladesine; Gluconates; Glutathione; Graft Survival; Hydroxyethyl Starch Derivatives; Insulin; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Phosphates; Raffinose; Rats; Reperfusion Injury; Trehalose | 2008 |
PGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury.
Topics: Adenosine; Allopurinol; Alprostadil; Animals; Bucladesine; Dexamethasone; Drug Synergism; Glutathione; Hemodynamics; In Vitro Techniques; Insulin; Interleukin-1; Ischemia; Lung; Male; Organ Preservation Solutions; Pregnatrienes; Pulmonary Circulation; Raffinose; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 1997 |
Dibutyryl cyclic adenosine monophosphate attenuates lung injury caused by cold preservation and ischemia-reperfusion.
Topics: Animals; Bucladesine; Cold Temperature; Endothelium, Vascular; Lung; Lung Transplantation; Male; Microscopy, Electron; Organ Preservation Solutions; Pulmonary Artery; Rats; Reperfusion Injury; Time Factors | 1997 |
Effect of dibutyryl cyclic adenosine monophosphate on skeletal muscle reperfusion injury in the rat.
Topics: Adenine Nucleotides; Animals; Blood Flow Velocity; Bucladesine; Disease Models, Animal; Endothelium, Vascular; Lipid Peroxides; Male; Microscopy, Electron; Muscle, Skeletal; Phosphocreatine; Rats; Rats, Inbred Lew; Reperfusion Injury | 1997 |
Protective agents used as additives in University of Wisconsin solution to promote protection against ischaemia-reperfusion injury in rat lung.
Topics: Adenosine; Allopurinol; Analysis of Variance; Animals; Anti-Inflammatory Agents; Bucladesine; Dexamethasone; Glutathione; Insulin; Lung; Lung Transplantation; Male; Organ Preservation Solutions; Organ Size; Prostaglandins E; Raffinose; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tissue Preservation; Vascular Resistance | 1998 |
Effects of dibutyryl cyclic adenosine monophosphate on the ultrastructure of endothelial cells in rat lungs cold preserved for 15 hours.
Topics: Animals; Arterioles; Bucladesine; Cryopreservation; Endothelium, Vascular; Ischemia; Lung; Male; Microscopy, Electron; Pulmonary Circulation; Rats; Rats, Inbred Lew; Reperfusion Injury; Time Factors | 2000 |
Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.
Topics: Adenosine; Analysis of Variance; Animals; Bucladesine; Caffeine; Kidney; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Reperfusion Injury; Vasodilation; Xanthines | 2001 |
Significance and molecular targets of protein kinase A during cAMP-mediated protection of cold stored liver grafts.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Bucladesine; Carrier Proteins; Cryopreservation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochrome c Group; Humans; In Situ Nick-End Labeling; Liver; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Rats; Reperfusion Injury; Second Messenger Systems; Transplants | 2001 |
Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP.
Topics: Animals; Bucladesine; Capillary Permeability; Colforsin; Cyclic AMP; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Male; Perfusion; Pulmonary Circulation; Rats; Reperfusion Injury | 1992 |
Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury.
Topics: Animals; Bucladesine; Capillaries; Capillary Permeability; Colforsin; Cyclic AMP; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Rabbits; Reperfusion Injury; Vascular Resistance | 1992 |